维普中文期刊产品整合服务
95篇 您的检索式:作者名="OSAKO Y"
    题名 作者 年代 出处 被引量
1超重和肥胖的全球趋势及其与心血管疾病发生率之间的关系显示文摘虽然超重和肥胖的全球发病率逐日上升,但在不同地区、国家和性别中的发病趋势仍存在差异。据世界卫生组织报道,全球多个地区由体质量指数(body mass index,BMI)≥25kg/m2定义的超重/肥胖发生率几乎接近一半人口,有的甚至超过了一半,如美洲(61.1%),欧洲(54.8%)和东地中海地区(46.0%),然而,在非洲(26.9%),东南亚(13.7%)和西太平洋地区(25.4%),超重/肥胖发生率较低。刘莉 叶鹏 Yatsuya H Li Y Hilawe EH Ota A Wang C Chiang C Zhang Y Uemura M Osako A Ozaki Y Aoyama A Circ J 2014中华高血压杂志2014,22,12:8
2A pilot and field investigation on mobility of PCDDs/PCDFs in landfiel site with municipal solid waste incineration residue 显示文摘Osako M Kim Y J Lee D H 2002Chemosphere2002,48,8:1
3Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis 显示文摘Nishimura R Osako T Okumura Y 2011World Journal of Surgical Oncology2011,9,:1
4Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats显示文摘Harada N Ninomiya C Osako Y 2004Obes Res2004,12,7:1
5Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial 显示文摘Kaji R Osako Y Suyama K 2010Neurol2010,257,8:1
6Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast car- cinoma显示文摘Ide Y Horii R Osako T 2011Pathol Int2011,61,:1
7Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvantchemotherapy for op erable HER2-negative breast cancer显示文摘Osako T Nishimura R Okumura Y 2012Exp Ther Med2012,3,1:1
8Differences in free amino acid composition between testis and ovary of seaurchin Anthocidaris crassispina during gonadal development显示文摘Osako K Fujii A Ruttanapornvareesakul Y 2007Fisheries Science2007,73,:1
9Clinical significance of Ki67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis 显示文摘Nishimura R Osako Okumura Y 2010Breast Cancer2010,17,4:1
10Botulinum toxin type A in post-stroke lower limb spasticity:a multicenter,double-blind,placebo-controlled trial显示文摘Kaji R Osako Y Suyama K 2010J Neurol2010,257,8:1
11Changes in the ER,PgR,HER2,P53 and Ki-67 biological markers between primary and recurrent breast cancer:discordance rates and prognosis显示文摘Nishimura R Osako T Okumura Y 0,,01:1
12A pilot and field investigation on mobility of PCDDs/PCDFs in landfill site with municipal solid waste incineration residue 显示文摘OSAKO M KIM Y J LEE D H 2002Chemosphere2002,48,8:1
13Framework for optimal design of porous sca?old microstructure by computational simulation of bone regeneration显示文摘Adachi T Osako Y Tanaka M Hojo M Hollister SJ 2006Biomaterials2006,27,:1
14Unusual presentation of intraparenchymal renal artery aneurysm mimicking cystic renal cell carcinoma: a case report 显示文摘Osako Y Tatarano S Nishiyama K 2011Int J Urol2011,18,7:1
15Development of heat hyperalgesia and changes of TRPVl and NGF expression in rat dorsal root ganglion following joint immobilization 显示文摘NISHIGAMI T OSAKO Y IKEUCHI M 2013Physiol Res2013,62,2:1
16Predictive significance ofthe proportion of ER-positive or PgR-positive tumor cells in responseto neoadjuvant chemotherapy for operable HER2 -negative breast can-cer显示文摘Osako T Nishimura R Okumura Y 2012Experimental Therapeutic Medicine2012,3,1:1
17Changes in the ER,PgR,HER2,p53 and Ki-67 biological markers between primary and recurrent breast cancer:discordance rates and prognosis显示文摘Nishimura R Osako T Okumura Y 2011World J Surg Oncol2011,9,:1
18Leaching of brominated flame retardants in leachate from landfills in Japan显示文摘Osako M Kim Y J Ma K C 0,,10:1
19Botulinum toxin type A in poststroke lower limb spasticity:a multicenter,double-blind,placebocontrolled trial显示文摘Kaji R Osako Y Suyama K 0,,08:1
20Predictive significance of the proportion of ER-positive or Pg R-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer显示文摘Osako T Nishimura R Okumura Y 2012Exp Ther Med2012,3,1:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费